免缝合快速释放瓣膜行孤立主动脉瓣置换术在不同手术风险患者中的手术结局:SURD-IR登记研究
基于SURD-IR国际登记2007—2017年数据,分析2057例首次孤立主动脉瓣置换患者,按EuroSCORE分为低危(<5,n=500)、中危(5-10,n=901)、高危(11-20,n=500)和极高危(>20,n=156)四组。结果显示各组院内死亡率分别为1.6%、0.8%、1.9%和2.7%,组间无显著差异,术后并发症率亦相似。结论认为免缝合快速释放生物瓣行外科主动脉瓣置换术安全有效,在高风险患者中尤为明显。
要点
- 免缝合快速释放瓣膜行孤立主动脉瓣置换术在各风险组院内死亡率低且无显著差异。
- 微创入路在全部风险组中均占多数(总体74.1%)。
- Perceval瓣膜在高危和极高危患者中使用更频繁。
核心结论
- 使用免缝合快速释放生物瓣行外科主动脉瓣置换术可获得优异结果,是严重主动脉瓣狭窄安全有效的治疗选择。
- 该结论在高风险患者中似乎尤为适用。
研究设计与样本
- 回顾性登记研究,数据来自Sutureless and Rapid Deployment Aortic Valve Replacement International Registry(SURD-IR),收集2007—2017年数据。
- 共3651例患者纳入登记,其中2057例首次孤立主动脉瓣置换患者纳入本分析。
- 按EuroSCORE分为低危(<5,n=500)、中危(5-10,n=901)、高危(11-20,n=500)和极高危(>20,n=156)。
主要发现
- 总体74.1%患者采用微创入路,且在全部风险类别中均为最常见入路(>50%)。
- Perceval瓣膜使用频率高于其他器械,尤其在高危和极高危患者中。
- 院内死亡率在低危、中危、高危和极高危组分别为1.6%、0.8%、1.9%和2.7%,亚组间无显著差异。
- 术后并发症率在不同风险类别间相似。
临床怎么用
- 对于严重主动脉瓣狭窄患者,免缝合快速释放生物瓣行外科主动脉瓣置换术可作为安全有效的治疗选择。
- 在高手术风险患者中,该技术可能尤其具有应用价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The ideal strategy for the treatment of severe aortic valve stenosis in patients of varying risk categories has become a debated topic in the last years: should the transcatheter or surgical approach be adopted? The aim of this study was to evaluate the outcomes of low-, intermediate-, high- and very high-risk patients undergoing sutureless, rapid deployment aortic valve replacement. METHODS: From 2007 to 2017, data on a total of 3651 patients were collected from the Sutureless and Rapid Deployment Aortic Valve Replacement International Registry (SURD-IR). Of these, 2057 patients who underwent primary isolated aortic valve replacement were considered for this analysis and classified as being at low (EuroSCORE <5; n = 500), intermediate (EuroSCORE 5-10; n = 901), high (EuroSCORE 11-20; n = 500) and very high (EuroSCORE >20; n = 156) preoperative risk. RESULTS: Overall, a less invasive approach was used in 74.1% of patients and represented the most frequent (>50%) approach in all risk categories. The Perceval prosthesis was used more frequently than other devices, especially in patients at high and very high risk. Hospital mortality was 1.6%, 0.8%, 1.9% and 2.7% in low-, intermediate-, high- and very high-risk patients, respectively, with no significant differences among subgroups. Similarly, postoperative complication rates were similar across the different risk categories. CONCLUSIONS: Surgical aortic valve replacement using sutureless, rapid deployment biological valve prostheses is associated with excellent results and represents a safe and effective treatment option for patients with severe aortic valve stenosis. This seems to be particularly true in patients with a higher risk profile.
引用
- Santarpino G, Berretta P, Fischlein T, et al. Operative outcome of patients at low, intermediate, high and 'very high' surgical risk undergoing isolated aortic valve replacement with sutureless and rapid deployment prostheses: results of the SURD-IR registry. Eur J Cardiothorac Surg. 2019. PMID: 30689828. doi:10.1093/ejcts/ezy477
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。